AbCellera Biologics Inc.ABCLNASDAQ
Loading
Year-over-year revenue growth rate
5Y CAGR
-28.3%/yr
Long-term compound
Percentile
P93
Near historical high
vs 5Y Ago
0.2x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 400.88% |
| Q3 2025 | -47.58% |
| Q2 2025 | 303.40% |
| Q1 2025 | -16.14% |
| Q4 2024 | -22.39% |
| Q3 2024 | -11.14% |
| Q2 2024 | -26.43% |
| Q1 2024 | 8.44% |
| Q4 2023 | 39.10% |
| Q3 2023 | -34.38% |
| Q2 2023 | -17.52% |
| Q1 2023 | -43.41% |
| Q4 2022 | -78.75% |
| Q3 2022 | 120.80% |
| Q2 2022 | -85.50% |
| Q1 2022 | 127.22% |
| Q4 2021 | 2429.61% |
| Q3 2021 | -80.07% |
| Q2 2021 | -86.37% |
| Q1 2021 | -2.49% |
| Q4 2020 | 2120.77% |
| Q3 2020 | -16.62% |
| Q2 2020 | 141.10% |
| Q1 2020 | 45.42% |
| Q4 2019 | -7.20% |
| Q3 2019 | 39.20% |
| Q2 2019 | -0.00% |
| Q1 2019 | 0.00% |